Advertisement

February 18, 2020

Cerus Endovascular’s Contour Neurovascular System Receives CE Mark Approval to Treat Intracranial Aneurysms

February 18, 2020—Cerus Endovascular Ltd. announced that it has received European CE Mark approval for its Contour neurovascular system in the treatment of intracranial aneurysms.

The Contour system is a fine-mesh braid that is deployed across the neck of the aneurysm sac and provides a combination of flow diversion and flow disruption through a single device implant. Cerus expects to begin commercial sales via a controlled market release across the European Union during the second quarter of 2020.

According to the company, CE Mark approval was based on data generated from the company’s two European studies evaluating the safety and efficacy of the Contour neurovascular system, focusing on unruptured intracranial aneurysms. The most recent study, which was completed in 2019, was conducted at six sites in Germany, Austria, and Denmark, with data to be presented later this year. Data from the earlier study, which included four sites in the United Kingdom and Hungary, were presented at scientific conferences in early 2020.

Advertisement


February 18, 2020

Japanese Study Supports EVAR for Ruptured AAA in Octogenarian Patients With Suitable Anatomy

February 17, 2020

Role of Carotid Stents and Cerebral Protection on Cerebral Microembolization During CAS Evaluated